| Mantis, Nicholas J. |
Wadsworth Center
United States |
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology |
3U01CA260508-02S1 |
|
Indu Kohaar, Ph.D. |
| Nechiporuk, Alex |
Oregon Health & Science University
United States |
High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies. |
1R21CA260025-01A1 |
|
Rachel Altshuler, Ph.D. |
| Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
High-throughput immunoproteomics for cancer biomarker discovery |
5U2CCA271903-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Chung, Michael Hoonbae |
Emory University
United States |
HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) |
5UG1CA275400-02 |
|
Silvina Frech, Ph.D., M.S. |
| Visovsky, Constance G. |
University Of South Florida
United States |
Home-Based Physical Activity Intervention for Taxane-Induced CIPN |
5R01CA229681-05 |
|
Goli Samimi, Ph.D., M.P.H. |
| Zhao, Hua |
University Of Virginia
United States |
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor |
7U01CA260731-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Vigneron, Daniel B |
University Of California, San Francisco
United States |
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients |
5U01CA232320-05 |
PAR-16-089 (U01) |
Richard Mazurchuk, Ph.D. |
| Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr
United States |
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium |
5UG1CA242609-05 |
|
Donald Johnsey |
| Shuck, Sarah C. |
Beckman Research Institute/City Of Hope
United States |
Identification of metabolic adducts associated with prostate cancer progression in African American men |
1R21CA282612-01 |
|
Guillermo Marquez, Ph.D. |
| Digiovanni, John |
University Of Texas At Austin
United States |
Identification of Natural Compound Combinations for Prevention of Prostate Cancer |
5R01CA228404-05 |
|
Marjorie Perloff, M.D. |